Trautmann, M E <br/><br/>
Use of glucagon-like peptide-1 receptor agonists among individuals on basal insulin requiring treatment intensification.  [electronic resource] 

 -  Diabetic medicine : a journal of the British Diabetic Association  06 2018 
 - 694-706 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>1464-5491 
<br/><br/><label>Standard No.: </label>10.1111/dme.13610  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Diabetes Mellitus, Type 2--drug therapy<br/>Drug Therapy, Combination<br/>Glucagon--physiology<br/>Glycated Hemoglobin--metabolism<br/>Humans<br/>Hyperglycemia--prevention & control<br/>Hypoglycemia--chemically induced<br/>Hypoglycemic Agents--therapeutic use<br/>Incretins--physiology<br/>Insulin Glargine--therapeutic use<br/>Insulin, Long-Acting--therapeutic use<br/>Peptides--therapeutic use<br/>Postprandial Period--physiology<br/>Treatment Outcome<br/>Glucagon-Like Peptide-1 Receptor Agonists